The expression level of β-catenin in lung cancer cells with cir-ITCH hyperexpression was further confirmed by western blotting analysis (Figure 4(b)), and it was discovered that there was an obvious decrease in β-catenin levels, while no change in Wnt3a expression was shown. The gene discussed is WNT3A; the disease is lung cancer.